Research Article | Open Access
Magalí Blanco, Glenda Ernst, Alejandro Salvado, Eduardo Borsini, "Impact of Mask Type on the Effectiveness of and Adherence to Unattended Home-Based CPAP Titration", Sleep Disorders, vol. 2019, Article ID 4592462, 7 pages, 2019. https://doi.org/10.1155/2019/4592462
Impact of Mask Type on the Effectiveness of and Adherence to Unattended Home-Based CPAP Titration
Objectives. To compare interfaces performance during home-based automatic titration (APAP). Methods. Retrospective study based on APAP titration from Obstructive Sleep Apnea Syndrome (OSA) patients. Results. 707 patients, 513 men (70.6%), were titrated. Masks were 104 pillows (14.7%), group I (GI); 532 nasal (75.2%), group II (GII); and 71 oronasal masks (10%), group III (GIII). We found differences in effective pressure to the device (P90/P95) (GI: 7.13±1.9 vs. GII: 8.3±2.1 vs. GIII: 9.3±2.6 cmH2O, p <0.001) but not in final pressure titrated manually (GI: 7.9±1.4 vs. GII: 8.6±1.6 vs. GIII: 9.2±1.9 cm of H2O, p >0.5), where lower residual AHI for pillows was p <0.001 and leaks for nasal were p <0.001. No differences were found in compliance (hours) (GI: 6.3±1.2 vs. GII: 6.2±1.1 vs. GIII: 6.1±1.0, p <0.4). Conclusion. During auto-adjusting titration by CPAP-naïve patients, nasal masks had lower leak rates and nasal pillows presented a similar performance.
Continuous positive airway pressure (CPAP) is the treatment of choice for patients with moderate to severe obstructive sleep apnea hypopnea syndrome (OSA). CPAP may be administered with a nasal interface, an oronasal mask, or nasal pillows [1, 2]. Even though CPAP therapy is known to be effective and long-term adherence has been consistent and repeated in clinical trials, reported adherence ranges from 40 to 80%. However, 10-20% of patients discontinue CPAP therapy after the first night of use due to discomfort from mask-related side effects [3–5].
It has been reported that half of CPAP patients experience mask-related adverse effects, such as leaks, pain, pressure ulcers on the bridge of the nose, nasal congestion, and a dry mouth or nose [5–8]. The type of interface has been found to exert an influence on therapy tolerance and adherence. Several studies have shown that oronasal masks have been associated with higher residual apnea-hypopnea indexes (rAHI) and higher pressures than nasal masks when used by the same patient [9–14].
With the purpose of reducing the occurrence of undesirable events, manufacturers have designed and marketed new masks. Among them are nasal pillows with two nostril inserts. Even though nasal masks are considered as the first-line interface to treat sleep obstructive disorders, some studies have shown that nasal pillows could be equally effective [7, 8, 15].
Auto-adjusting or automatic positive airway pressure devices use pressure-adjusting algorithms to detect respiratory events. Healthcare centers with a heavy demand for sleep tests and long waiting lists have suggested APAP as a nonconventional titration method. Auto-adjusting devices were not originally designed for this purpose. However, their use has spread because their internal memory can record working pressure variations derived from airway obstruction events throughout the night. These recordings enable analysis of such variable according to each individual patient.
APAP titration can be used at home for several nights, collecting a more extensive range of data. This approach allows physicians to assess night-to-night variability, shortens waiting lists, and lowers the operating costs related to conventional titration [16–20].
According to the last recommendations issued by the American Academy of Sleep Medicine (AASM), APAP titration is a valid option for patients with no significant comorbidities, provided that data are analyzed manually by experienced personnel  to titrate pressure at the sleep laboratory or at patients’ homes using a self-administered approach without additional monitoring [21, 22].
The performance of masks and their impact on unmonitored titration processes have not been deeply studied. The objective of this study is to compare different interfaces in terms of short-term adherence and effectiveness in patients with obstructive sleep apnea during unattended home-based titration
2. Materials and Methods
2.1. Study Design
This is a retrospective and observational study conducted at Hospital Británico in the city of Buenos Aires, Argentina. The protocol was approved by the institutional review board and ethics committee (CRIHB number: #844).
This is a retrospective study based on home APAP titrations systematically collected between October 2015 and December 2017 (26 months) from OSA patients referred to the Sleep Unit for a demonstration on the use of interfaces in an unmonitored setting. Researchers only included recordings from CPAP-naïve patients. Authors were not involved in the indication for CPAP therapy, which was prescribed by each patient’s treating pulmonologist.
Patients diagnosed with obesity-hypoventilation syndrome, periodic breathing, or central apnea at baseline and those who needed other types of treatment (i.e., ventilation with two pressure levels, servo-controlled ventilation, and concomitant oxygen) were excluded from the study.
Baseline apnea-hypopnea index (AHI) in events/hour was obtained from PSG or RP recordings. Sleep scoring and standard definition according to severity of apnea and hypopnea syndrome was defined according to the traditional criteria of the American Academy of Sleep Medicine. OSA was classified in mild: IAH 5-14.9, moderate: IAH 15 to 30, and severe: > 30 events/hour [23, 24].
Anthropometric data (i.e., body mass index (BMI) and neck circumference (NC) were measured before delivering CPAP machines.
2.3. Mask Selection
Mask type, size, and model were selected according to our Unit’s standardized procedure after a demonstration of the different interfaces performed by a physical therapist trained in sleep medicine. CPAP devices included either a standard nasal mask (an interface that covers the nose but not the mouth) or nasal pillows (mask with nasal inserts). Patients who did not tolerate smaller masks or who preferred larger masks were shown different models of oronasal masks.
After said demonstration, CPAP devices were turned on and tested for a few minutes with masks on. Patients were asked about comfort level and, if necessary, adjustments were made for greater tolerance and proper fitting. Finally, patients were asked to choose a mask.
Final mask selection depended on patient’s preferences and the result of a 20-minute leak test of the APAP device. Patients and their spouses or roommates received basic training on the use of CPAP devices and masks. In addition, they were invited to take part in the patient education program offered at our Sleep Unit called “School of CPAP” .
2.4. Home-Based Unattended Auto-Adjusting CPAP Titration
We used auto-adjusting System One, Dream Station (Philips-Respironics; USA), S9 and Air Sense (ResMed-Sydney; Australia) devices. Unlike conventional CPAP, which uses fixed continuous positive airway pressure, APAP algorithms automatically adjust pressure through a flow sensor and adjust working pressure in response to respiratory events (apneas, hypopneas, limited inspiration, and snoring) until a normal respiratory pattern resumes. Minimum pressure was set at 4 cm of H2O and maximum pressure at 15 cm of H2O. Ramp features and expiratory pressure relief were not used.
Titration periods were consistent with effective Sleep Unit procedures (from 3 to 7 days) depending on the availability of appointments and devices. All nights with CPAP utilization in each patient were analyzed. When there were periods of no use or excessive leakage (above the compensation limit of the device), the night was not considered for the analysis.
Titration data were obtained after downloading the information from the CPAP machine SD card using Encore Pro II Philips-Respironics and ResScan-ResMed or ResMed Air View online platform for remote monitoring (Figures 1 and 2).
Effective pressure data were obtained after visual analysis of pressure/time curves by physicians and physical therapists trained in sleep medicine (Figure 2). Researchers analyzed > 20.000 hours of recordings of APAP use and obtained data on compliance, mean leak, and residual AHI. Minimum adherence was defined as using CPAP effectively at least for 4 hours/night during each study night. Optimum titration was defined as a rAHI of < 5 events per hour (events/hour). Titration was deemed acceptable when rAHI ranged between 5 and 10 events/hour.
Researchers compared APAP recordings according to interface type.
2.5. Statistical Analysis
Categorical variables are expressed as percentages and numerical variables as mean and standard deviation (±). Differences were compared using Fisher’s test, Mann–Whitney test, or χ2. Titration pressures were compared using linear regression analysis. Statistical analyses were conducted using Graph Pad Prism-7.04™ software.
707 patients were titrated: 513 men (70.6%) and 194 women. Table 1 summarizes patient’s characteristics.
Values expressed as means and standard deviation (±).
According to the AHI per hour of sleep on polysomnography (PSG) or recording time on respiratory polygraphy (RP), patients were classified as having mild (4.5%) OSA (baseline AHI (mean) of 10.2 ± 3.3 events/hour), moderate (36.5%) OSA (AHI of 22.2 ± 4.1), and severe (59%) OSA (AHI of 47.7 ± 16.4). The mean titration period was 3.2 ± 0.8 nights.
The study assessed 3 types of masks categorized into 3 groups: 104 nasal pillows (14.7%) in group I (GI); 532 nasal masks (75.2%) in group II (GII); and 71 oronasal masks (10%) in group III (GIII). Group I had a larger proportion of moderate OSA patients, while group III mostly consisted of patients with severe OSA (Figure 3).
Compliance was similar across groups (6.2 ± 1.1 vs. 6.3 ± 1.2 vs. 6.1 ± 1.1 hours/night) p > 0.5. There were no differences between groups in terms of age (57 ± 12 vs. 59.4 ± 12 vs. 59.1 ± 12.2 years), neck circumference (41.4 ± 2.3 vs. 43.4 ± 4.1 vs. 43.7 ± 3.3 cm), body mass index (33.1 ± 6.6 vs. 34.2 ± 6.8 vs. 34.1 ± 6.4 kg/m2), and baseline Epworth Sleepiness Scale ESS (9.8 ± 5.7 vs. 9.8 ± 5.8 vs. 8.7 ± 5.7 scores) p > 0.5.
Our findings reveal differences in effective pressure levels of obtained titration according to the device (P90/P95) (GI: 7.13 ± 1.9 vs. GII: 8.3 ± 2.1 vs. GIII: 9.3 ± 2.6 cmH2O, p < 0.001) (Figure 4(a)). Pressure values titrated through visual analysis of pressure-time curves were similar for all study nights across groups (GI: 7.9 ± 1.4 vs. GII: 8.6 ± 1.6 vs. GIII: 9.2 ± 1.9 cm of H2O, p > 0.5).
Residual AHI was lower for nasal pillows (GI: 3.7 ± 2.9 vs. GII: 4.6 ± 4.1 vs. GIII: 7.6 ± 5.2 events/hour, p < 0.001) (Figure 4(b)).
Leaks were considered acceptable in all groups but significantly lower for nasal masks (GI: 18.6 ± 7.7 vs. GII: 15 ± 9.8 vs. GIII: 20.4 ± 10.4 liters/min, p < 0.001) (Figure 4(c)).
Finally, no differences were found in terms of CPAP use per night (in hours) among the different types of masks (GI: 6.3 ± 1.2 vs. GII: 6.2 ± 1.1 vs. GIII: 6.1 ± 1.0, p < 0.4) (Figure 4(d)).
The main finding of this study revealed that nasal pillows were as effective as nasal masks at treating obstructive disorders with CPAP therapy and achieving adherence during titration in CPAP-naïve patients.
According to our data, CPAP-naïve patients can correctly use and adhere to auto-adjusting CPAP therapy during unmonitored titration after basic training and an interface-selection process.
Literature validates the use of auto-adjusting devices for titration purposes. This approach has several advantages: procedures are simpler, patients do not need an appointment with the sleep laboratory, and sleep laboratories are used only for cases where home-based titration is not effective or possible [16–22].
We conducted a visual analysis of pressure/time and leak/time curves to define final effective pressure. In statistical analysis, bench studies tend to show higher values for automatic algorithms because the software cannot exclude periods of improper mask fit . In our study, visual analysis allowed us to identify and exclude pressure values related to those events. In addition, the rAHI value in this type of devices is reliable when < 10 events/hour is recorded, as compared to manual titration by PSG . Our results, however, cannot be extrapolated to all available algorithms because of potential marked variations in the performance of each device. Our analysis shows that a careful interface selection and initial guidance enable most CPAP-naïve patients to use CPAP therapy > 4 hours/night and correct their AHI.
Some studies that assessed adherence after 3 months showed that APAP titration improves mean compliance in approximately one hour, when compared to PSG titration at the sleep laboratory [28–30]. In our study, mean compliance with auto-adjusting CPAP in CPAP-naïve patients was > 6 hours in a mean period of > 3 nights.
The influence of masks on CPAP working pressure has been previously described  as being higher for oronasal masks. This is consistent with our findings, although only a minority of patients in our series used this type of mask. Borel et al.  conducted a descriptive study based on 2.311 OSA patients and found statistically significant differences between the 3 groups of masks in terms of CPAP titration pressure, which was higher with oronasal masks and lower with nasal masks and nasal pillows. Conversely, adherence was better with smaller masks. We found lower pressures (P90/P95) in the groups of nasal masks and pillows. A remarkable finding was that oronasal masks were preferred by more severe cases, while nasal pillows were mostly chosen by patients with mild-moderate AHI.
Interfaces have proved essential in promoting adherence. Meslier et al.  carried out a survey among > 3.000 patients and found that half of them rated their interface as being “good” or “very good”, while the other half reported they were not satisfied with it . Available data shows that a first good experience during the implementation of treatment (during the first week) is crucial for long-term adherence [31–34].
During the last years, some studies have shown that the performance of nasal pillows is similar to that of nasal masks. Therefore, nasal pillows could become first-line choice for CPAP therapy [8, 13, 15]. In 2011, Ryan et al.  reported that 62% of patients preferred nasal pillows over nasal masks. In our sample, nasal pillows and nasal masks showed equally lower leak rates, confirming prior observations.
A recent literature review analyzed 2 properly designed studies that compared the 3 types of masks in terms of CPAP therapy efficacy. Ebben et al.  assessed 55 OSA patients who were randomized to oronasal masks, nasal masks, or nasal pillows for CPAP titration. Nasal masks and nasal pillows were similar in terms of CPAP levels and consistently lower than oronasal masks. They found no differences in terms of residual AHI.
We found no difference in CPAP compliance with the 3 types of masks, following the titration protocol currently in force in our center.
One of the limitations of our study is its retrospective design. In addition, a source of bias may derive from the lack of randomization to mask type. Still, our study is based on a series of consecutive patients that underwent the same clinical protocol.
The education session and practical demonstration of available interfaces seemed effective and allowed us to achieve acceptable adherence in CPAP-naïve patients. Besides, allowing patients to take an active part in the mask selection process may have exerted a positive influence in treatment adherence. Higher socioeconomic levels and older ages are associated with better compliance and may partially account for our findings, since we analyzed an adult population (≈ 60 years of age) referred from a private care setting for home-based titration (possible selection bias). On the other hand, clinical management by trained personnel and the influence of cognitive-behavioral strategies could also have improved short-term compliance [30, 35].
During home-based auto-adjusting CPAP titration by CPAP-naïve patients, nasal masks were selected by most participants and had lower leak rates. Nasal pillows presented a similar performance.
The clinical information about patients and titration test used to support the findings of this study may be released upon application to the institutional revision committee of Hospital Británico de Buenos Aires, Argentina, who can be contacted at CRI@hbritanico.com.ar.
No funds or other benefits were received by investigators or Sleep Unit personnel for developing the protocol or recruiting/following up patients.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- C. E. Sullivan, F. G. Issa, M. Berthon-Jones, and L. Eves, “Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares,” The Lancet, vol. 1, no. 8225, pp. 862–865, 1981.
- P. Gay, T. Weaver, D. Loube, and C. Iber, “Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults,” SLEEP, vol. 29, no. 3, pp. 381–401, 2006.
- T. E. Weaver and R. R. Grunstein, “Adherence to continuous positive airway pressure therapy: the challenge to effective treatment,” Proceedings of the American Thoracic Society, vol. 5, no. 2, pp. 173–178, 2008.
- T. E. Weaver and A. M. Sawyer, “Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions,” Indian Journal of Medical Research, vol. 131, no. 2, pp. 245–258, 2010.
- G. K. Shapiro and C. M. Shapiro, “Factors that influence CPAP adherence: an overview,” Sleep and Breathing, vol. 14, no. 4, pp. 323–335, 2010.
- M. Kohler, D. Smith, V. Tippett, and J. R. Stradling, “Predictors of long-term compliance with continuous positive airway pressure,” Thorax, vol. 65, no. 9, pp. 829–832, 2010.
- C. A. Massie and R. W. Hart, “Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure,” CHEST, vol. 123, no. 4, pp. 1112–1118, 2003.
- S. Ryan, J. F. Garvey, V. Swan, R. Behan, and W. T. McNicholas, “Nasal pillows as an alternative interface in patients with obstructive sleep apnoea syndrome initiating continuous positive airway pressure therapy,” Journal of Sleep Research, vol. 20, no. 2, pp. 367–373, 2011.
- M. R. Ebben, S. Milrad, J. P. Dyke, C. D. Phillips, and A. C. Krieger, “Comparison of the upper airway dynamics of oronasal and nasal masks with positive airway pressure treatment using cine magnetic resonance imaging,” Sleep and Breathing, vol. 20, no. 1, pp. 79–85, 2016.
- M. Teo, T. Amis, S. Lee, K. Falland, S. Lambert, and J. Wheatley, “Equivalence of nasal and oronasal masks during initial CPAP titration for obstructive sleep apnea syndrome,” SLEEP, vol. 34, no. 7, pp. 951–955, 2011.
- J. P. Bakker, A. M. Neill, and A. J. Campbell, “Nasal versus oronasal continuous positive airway pressure masks for obstructive sleep apnea: a pilot investigation of pressure requirement, residual disease, and leak,” Sleep and Breathing, vol. 16, no. 3, pp. 709–716, 2012.
- M. R. Ebben, T. Oyegbile, and C. P. Pollak, “The efficacy of three different mask styles on a PAP titration night,” Sleep Medicine, vol. 13, no. 6, pp. 645–649, 2012.
- J. C. Borel, R. Tamisier, S. Dias-Domingos et al., “Type of mask may impact on continuous positive airway pressure adherence in apneic patients,” PLoS ONE, vol. 8, no. 5, Article ID e64382, 2013.
- M. R. Ebben, M. Narizhnaya, A. Z. Segal, D. Barone, and A. C. Krieger, “A randomised controlled trial on the effect of mask choice on residual respiratory events with continuous positive airway pressure treatment,” Sleep Medicine, vol. 15, no. 6, pp. 619–624, 2014.
- A. Lanza, S. Mariani, M. Sommariva et al., “Continuous positive airway pressure treatment with nasal pillows in obstructive sleep apnea: long-term effectiveness and adherence,” Sleep Medicine, vol. 41, pp. 94–99, 2018.
- P. Lloberes, E. Ballester, J. M. Montserrat et al., “Comparison of manual and automatic CPAP titration in patients with sleep apnea/hypopnea syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 6, pp. 1755–1758, 1996.
- F. Sériès, “Accuracy of an unattended home CPAP titration in the treatment of obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 1, pp. 94–97, 2000.
- R. Farré, J. M. Montserrat, J. Rigau, X. Trepat, P. Pinto, and D. Navajas, “Response of automatic continuous positive airway pressure devices to different sleep breathing patterns: A bench study,” American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 4, pp. 469–473, 2002.
- J. M. Montserrat, R. Farre, J. Duran et al., “Performance of an autoCPAP device and its utility used at home for fixed CPAP prescription in OSAS,” European Respiratory Journal, vol. 18, p. 515, 2001.
- J. M. Montserrat, R. Farré, and D. Navajas, “Automatic continuous positive airway pressure devices for the treatment of sleep apnea hypopnea syndrome,” Sleep Medicine, vol. 2, no. 2, pp. 95–98, 2001.
- T. I. Morgenthaler, R. N. Aurora, T. Brown et al., “Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007 - An American Academy of Sleep Medicine Report,” SLEEP, vol. 31, no. 1, pp. 141–147, 2008.
- F. Nogueira, C. Nigro, H. Cambursano, E. Borsini, J. Silio, and J. Ávila, “Practical guidelines for the diagnosis and treatment of obstructive sleep apnea syndrome,” Medicina (B Aires), vol. 73, no. 4, pp. 349–362, 2013.
- “Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients,” Portable Monitoring Task Force of the American Academy of Sleep Medicine Journal of Clinical Sleep Medicine, vol. 3, pp. 737–747, 2007.
- R. B. Berry, R. Budhiraja, D. J. Gottlieb et al., “Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine,” Journal of Clinical Sleep Medicine, vol. 8, no. 5, pp. 597–619, 2012.
- T. Décima, L. Maldonado, M. Bosio et al., “Cumplimiento abandono de CPAP en pacientes con síndrome de apneas del sueño. Encuesta luego de un programa de reuniones grupales,” Revista Americana de Medicina Respiratoria, vol. 4, pp. 197–206, 2013.
- K. Zhu, G. Roisman, S. Aouf, and S. P. Escourrou, “All APAPs are not equivalent for the treatment of sleep disordered breathing: a bench evaluation of eleven commercially available devices,” Journal of Clinical Sleep Medicine, vol. 11, no. 7, pp. 725–734, 2015.
- F. Gagnadoux, D. Pevernagie, P. Jennum et al., “Validation of the system one remstar auto A-Flex for obstructive sleep apnea treatment and detection of residual apnea-hypopnea index: a european randomized trial,” Journal of Clinical Sleep Medicine, vol. 13, no. 2, pp. 283–290, 2017.
- S. T. Kuna, I. Gurubhagavatula, G. Maislin et al., “Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 9, pp. 1238–1244, 2011.
- A. T. Mulgrew, N. Fox, N. T. Ayas, and C. F. Ryan, “Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study,” Annals of Internal Medicine, vol. 146, no. 3, pp. 157–166, 2007.
- C. L. Chai, A. Pathinathan, and B. Smith, “Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea,” Cochrane Database Syst Rev 2006: CD005308.
- L. Torre-Bouscoulet, M. S. Meza-Vargas, A. Castorena-Maldonado, M. Reyes-Zúñeiga, and R. Pérez-Padilla, “Autoadjusting positive pressure trial in adults with sleep apnea assessed by a simplified diagnostic approach,” Journal of Clinical Sleep Medicine, vol. 4, no. 4, pp. 341–347, 2008.
- K. E. Lewis, L. Seale, I. E. Bartle, A. J. Watkins, and P. Ebden, “Early predictors of CPAP use for the treatment of OSA,” Sleep, vol. 27, pp. 134–138, 2004.
- N. Meslier, T. Lebrun, V. Grillier-Lanoir, N. Rolland, C. Henderick, and J.-C. Sailly, “A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life,” European Respiratory Journal, vol. 12, no. 1, pp. 185–192, 1998.
- R. Budhiraja, S. Parthasarathy, C. L. Drake et al., “Early CPAP use identifies subsequent adherence to CPAP therapy,” SLEEP, vol. 30, no. 3, pp. 320–324, 2007.
- T. L. Giles, T. J. Lasserson, B. H. Smith, J. White, J. Wright, and C. J. Cates, “Continuous positive airways pressure for obstructive sleep apnoea in adults,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD001106, 2006.
Copyright © 2019 Magalí Blanco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.